Text Size A A A

Sun Pharma In The News

Tell a Friend Print Home » Media » Sun Pharma In The News

Sun drug gets US nod

Sun Pharmaceutical Industries Ltd has got the approval of US Food and Drug Administration for its generic valproic acid 250 mg capsule, a notice on the regulator's website said. Valproic acid capsules are marketed under the brand name Depakene in the US by Abbott Laboratories Inc. Valproic acid is am anticonvulsant and mood stabilising drug that is prescribed to treat various types of seizure-related disorders such as epilepsy, and also for bipolar disor­der and depression. Apart from Sun, two other companies, including Banner Pharmacaps Inc, have the US FDA ap­proval to market Depakene's generic.